Literature DB >> 23209323

Immunodeficiency and autoimmunity in H2-O-deficient mice.

Yapeng Gu1, Peter E Jensen, Xinjian Chen.   

Abstract

HLA-DO/H2-O is a highly conserved, nonpolymorphic MHC class II-like molecule expressed in association with H2-M in thymic epithelial cells, B lymphocytes, and primary dendritic cells. The physiological function of DO remains unknown. The finding of cell maturation-dependent DO expression in B lymphocytes and dendritic cells suggests the possibility that H2-O functions to promote the presentation of exogenous Ag by attenuating presentation of endogenous self-peptides. In the current study, we report that H2-O(-/-) mice spontaneously develop high titers of IgG2a/c antinuclear Abs (ANAs) with specificity for dsDNA, ssDNA, and histones. Reconstitution of RAG1(-)(/)(-) mice with T and B cells from H2-O(-)(/)(-) or wild-type mice demonstrated that production of ANAs requires participation of CD4(+) T cells from H2-O(-)(/)(-) mice. Bone marrow chimeras demonstrated that loss of H2-O expression in thymic epithelial cells did not induce ANAs, and that lack of H2-O expression in bone marrow-derived cells was sufficient to induce the autoimmune phenotype. Despite production of high titers of autoantibodies, H2-O(-/-) mice exhibit a delayed generation of humoral immunity to model Ags (OVA and keyhole limpet hemocyanin), affecting all major T-dependent Ig classes, including IgG2a/c. Ag presentation experiments demonstrated that presentation of exogenous Ag by H2-O(-/-) APC was inefficient as compared with wild-type APC. Thus, H2-O promotes immunity toward exogenous Ags while inhibiting autoimmunity. We suggest that H2-O, through spatially or temporally inhibiting H2-M, may enhance presentation of exogenous Ag by limiting newly generated MHC class II molecules from forming stable complexes with endogenous self-peptides.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23209323     DOI: 10.4049/jimmunol.1200993

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  HLA-DO Modulates the Diversity of the MHC-II Self-peptidome.

Authors:  Padma P Nanaware; Mollie M Jurewicz; John D Leszyk; Scott A Shaffer; Lawrence J Stern
Journal:  Mol Cell Proteomics       Date:  2018-12-20       Impact factor: 5.911

2.  Contribution of a Non-classical HLA Gene, HLA-DOA, to the Risk of Rheumatoid Arthritis.

Authors:  Yukinori Okada; Akari Suzuki; Katsunori Ikari; Chikashi Terao; Yuta Kochi; Koichiro Ohmura; Koichiro Higasa; Masato Akiyama; Kyota Ashikawa; Masahiro Kanai; Jun Hirata; Naomasa Suita; Yik-Ying Teo; Huji Xu; Sang-Cheol Bae; Atsushi Takahashi; Yukihide Momozawa; Koichi Matsuda; Shigeki Momohara; Atsuo Taniguchi; Ryo Yamada; Tsuneyo Mimori; Michiaki Kubo; Matthew A Brown; Soumya Raychaudhuri; Fumihiko Matsuda; Hisashi Yamanaka; Yoichiro Kamatani; Kazuhiko Yamamoto
Journal:  Am J Hum Genet       Date:  2016-08-04       Impact factor: 11.025

3.  Neutralizing Antibody Responses to Viral Infections Are Linked to the Non-classical MHC Class II Gene H2-Ob.

Authors:  Lisa K Denzin; Aly A Khan; Francesca Virdis; Jessica Wilks; Melissa Kane; Helen A Beilinson; Stanislav Dikiy; Laure K Case; Derry Roopenian; Michele Witkowski; Alexander V Chervonsky; Tatyana V Golovkina
Journal:  Immunity       Date:  2017-08-15       Impact factor: 31.745

Review 4.  Mechanisms of peptide repertoire selection by HLA-DM.

Authors:  Wouter Pos; Dhruv K Sethi; Kai W Wucherpfennig
Journal:  Trends Immunol       Date:  2013-07-05       Impact factor: 16.687

5.  A Single Locus Controls Interferon Gamma-Independent Antiretroviral Neutralizing Antibody Responses.

Authors:  Melissa Kane; Felicity Deiss; Alexander Chervonsky; Tatyana V Golovkina
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

6.  Fatal autoimmunity results from the conditional deletion of Snai2 and Snai3.

Authors:  Peter D Pioli; Xinjian Chen; Janis J Weis; John H Weis
Journal:  Cell Immunol       Date:  2015-02-24       Impact factor: 4.868

Review 7.  HLA-DM and HLA-DO, key regulators of MHC-II processing and presentation.

Authors:  Elizabeth D Mellins; Lawrence J Stern
Journal:  Curr Opin Immunol       Date:  2013-12-08       Impact factor: 7.486

8.  Pathways analysis of differential gene expression induced by engrafting doses of total body irradiation for allogeneic bone marrow transplantation in mice.

Authors:  Xinjian Chen; Yuanyuan Wang; Qiuxia Li; Schickwann Tsai; Alun Thomas; Judith A Shizuru; Thai M Cao
Journal:  Immunogenetics       Date:  2013-05-24       Impact factor: 2.846

Review 9.  What to do with HLA-DO/H-2O two decades later?

Authors:  Robin Welsh; Nianbin Song; Scheherazade Sadegh-Nasseri
Journal:  Immunogenetics       Date:  2019-01-26       Impact factor: 2.846

10.  MHC-II alleles shape the CDR3 repertoires of conventional and regulatory naïve CD4+ T cells.

Authors:  Nadezhda N Logunova; Valeriia V Kriukova; Pavel V Shelyakin; Evgeny S Egorov; Alina Pereverzeva; Nina G Bozhanova; Mikhail Shugay; Dmitrii S Shcherbinin; Mikhail V Pogorelyy; Ekaterina M Merzlyak; Vasiliy N Zubov; Jens Meiler; Dmitriy M Chudakov; Alexander S Apt; Olga V Britanova
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.